causal
Real-world cancer patients fare worse than trial patients
Idealized clinical trials enroll younger, healthier patients with fewer comorbidities than real-world patients, so trial survival overstates real-world benefit; in some cases real-world patients on the active drug live half as long as control-arm patients on a sugar pill in the trial, meaning the true absolute benefit of these agents is even smaller than the published figures.
causalpending
Speaker
Vinay PrasadEvidence Quote
“everything we know about idealized clinical trials is that the people on these clinical studies, they live longer than people in the real world”
Created: 6/13/2026, 12:28:36 AM
Your notes
Loading notes...